Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy Read more
Breckenridge Pharmaceutical Announces Final Approval of its ANDA Entecavir tablets (Baraclude) Read more